Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patients

Dan Wang(Breast Cancer Now), Caigang Liu(China Medical University)

Oncotarget

October 4, 2014

10.18632/oncotarget.2506

Cited by 160

Related Papers

Trends in Diabetes Treatment and Control in U.S. Adults, 1999–2018

|New England Journal of Medicine|2021|684

Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling

|Journal for ImmunoTherapy of Cancer|2019|231

Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells

|Breast Cancer Research|2014|146

Effectiveness of a non-physician community health-care provider-led intensive blood pressure intervention versus usual care on cardiovascular disease (CRHCP): an open-label, blinded-endpoint, cluster-randomised trial

|The Lancet|2023|139

Inflammatory Markers Predict Survival in Patients With Advanced Gastric and Colorectal Cancers Receiving Anti–PD-1 Therapy

|Frontiers in Cell and Developmental Biology|2021|65